Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
0.9985
-0.0215 (-2.11%)
Apr 4, 2025, 9:34 AM EDT - Market open
Rockwell Medical Revenue
In the year 2024, Rockwell Medical had annual revenue of $101.49M with 21.38% growth. Rockwell Medical had revenue of $24.67M in the quarter ending December 31, 2024, with 11.64% growth.
Revenue (ttm)
$101.49M
Revenue Growth
+21.38%
P/S Ratio
0.31
Revenue / Employee
$415,939
Employees
244
Market Cap
33.89M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 101.49M | 17.88M | 21.38% |
Dec 31, 2023 | 83.61M | 10.80M | 14.84% |
Dec 31, 2022 | 72.81M | 10.88M | 17.57% |
Dec 31, 2021 | 61.93M | -266.00K | -0.43% |
Dec 31, 2020 | 62.20M | 894.00K | 1.46% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
RMTI News
- 14 days ago - Rockwell Medical, Inc. (RMTI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Rockwell Medical Announces Fourth Quarter and Full-Year 2024 Financial and Operational Results - Business Wire
- 24 days ago - Rockwell Medical to Exhibit at DialysisTechConneXion42 in Booth# 112 - Business Wire
- 5 weeks ago - Rockwell Medical Named 'Great Place to Work' for Third Year in a Row - Business Wire
- 6 weeks ago - Rockwell Medical to Release Fourth Quarter and Full-Year 2024 Results on Thursday, March 20, 2025 - Business Wire
- 2 months ago - Rockwell Medical Adds Single-Use Bicarbonate Cartridge to Hemodialysis Concentrates Product Portfolio - Business Wire
- 3 months ago - Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World's Leading Provider of Dialysis Products and Services - Business Wire
- 3 months ago - UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card - GlobeNewsWire